A pungent gas typically associated with the smell of rotten eggs may hold a surprising secret to protecting the human brain. Researchers at Johns Hopkins Medicine have identified a specific protein that produces this gas—hydrogen sulfide—and found that it appears to be a critical component in how the brain forms memories and maintains its structural integrity.
The discovery centers on a protein called Cystathionine γ-lyase, or CSE. In a study published in Proceedings of the National Academy of Sciences, scientists demonstrated that when this protein is missing, the brain undergoes a series of degenerative changes that closely mirror the progression of Alzheimer’s disease. This suggests that the rotten egg brain gas, when produced in precise, minute quantities, acts as a vital shield for neurons.
For the more than 6 million people in the United States living with Alzheimer’s, the findings offer a potential modern avenue for treatment. Although current therapies struggle to stop or reverse the disease’s progression, targeting the CSE protein could provide a way to protect brain function and slow the onset of cognitive decline.
The research, led by Bindu Paul, Ph.D., an associate professor of pharmacology, psychiatry and neuroscience at the Johns Hopkins University School of Medicine, highlights a delicate biological balance. While hydrogen sulfide is toxic in large doses, the tiny amounts naturally generated by CSE within neurons appear to be essential for cognitive health.
The Link Between CSE Deficiency and Memory Loss
To determine exactly how the CSE protein influences the brain, the research team utilized genetically engineered mice. By comparing normal mice with those lacking the CSE enzyme, the scientists were able to isolate the protein’s role in spatial memory—the ability to remember directions and follow environmental cues.
The team employed a “Barnes maze,” a behavioral test where mice must find a hidden shelter to escape a bright light. The results revealed a stark divergence in cognitive ability as the mice aged. At two months old, both the normal mice and the CSE-deficient mice performed similarly, both finding the shelter within three minutes. However, by six months, the mice lacking the protein struggled significantly to find the escape route, while the normal group continued to succeed.
“The decline in spatial memory indicates a progressive onset of neurodegenerative disease that we can attribute to CSE loss,” says first author Suwarna Chakraborty, a researcher in Dr. Paul’s lab.
Cellular Decay and the Blood-Brain Barrier
The cognitive decline observed in the mice was not merely behavioral; it was rooted in physical damage at the cellular level. The researchers focused on the hippocampus, the region of the brain most critical for learning and memory. A healthy hippocampus relies on neurogenesis—the creation of new neurons—but the study found that proteins essential for this process were either reduced or entirely missing in mice without CSE.
Using high-powered electron microscopes, the team observed structural failures that are hallmarks of Alzheimer’s disease. These included:
- Vascular Damage: Large breaks in blood vessels, indicating a failure of the blood-brain barrier, which normally protects the brain from harmful substances in the blood.
- Neuronal Migration Issues: Newly formed neurons were unable to successfully reach the hippocampus, preventing them from contributing to memory formation.
- Oxidative Stress: Increased levels of DNA damage and oxidative stress, which contribute to the death of brain cells.
Sunil Jamuna Tripathi, a co-first author in Paul’s lab, noted that the mice lacking CSE were compromised at multiple levels, which correlated directly with the symptoms observed in human Alzheimer’s patients.
A Decade of Research into Neuroprotection
This latest breakthrough is the result of a long-term research trajectory. The work builds on foundational studies led by Solomon Snyder, M.D., professor emeritus of neuroscience, pharmacology and psychiatry at Johns Hopkins. The timeline of this discovery reflects a gradual narrowing of focus from general blood vessel function to specific neurodegenerative triggers.
| Year | Key Finding/Development |
|---|---|
| 2008 | CSE protein linked to blood pressure regulation and blood vessel function. |
| 2014 | Research indicates CSE supports brain health in mice with Huntington’s disease. |
| 2021 | Discovery that CSE malfunctions in Alzheimer’s mice; small hydrogen sulfide injections protect brain function. |
| Present | Confirmation that CSE alone is a major player in cognitive function and neurogenesis. |
Earlier experiments showed that very small injections of hydrogen sulfide could protect brain function in mice with Alzheimer’s. However, due to the fact that the gas is toxic in high concentrations, delivering it directly to the brain is unsafe. The current goal is to find ways to boost the brain’s own natural production of the gas by targeting the CSE protein itself.
“This most recent work indicates that CSE alone is a major player in cognitive function and could provide a new avenue for treatment pathways in Alzheimer’s disease,” says Dr. Snyder, who retired from the faculty in 2023.
What This Means for Future Treatment
The identification of CSE as a “major player” in cognitive health shifts the conversation toward potential therapeutic targets. If scientists can develop a way to safely enhance CSE activity or mimic its effects, they may be able to stabilize the blood-brain barrier and promote the survival of new neurons in the hippocampus.
While the study was conducted in mice, the mirroring of human Alzheimer’s symptoms—specifically the breakdown of the blood-brain barrier and the failure of neurogenesis—provides a strong biological rationale for further exploration in humans. The research was supported by extensive funding from the National Institutes of Health (NIH), the Department of Defense, and the American Heart Association.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The research team will continue to investigate how to safely maintain and boost the natural levels of hydrogen sulfide in neurons. The next phase of research will likely focus on identifying specific molecular triggers that can activate the CSE protein without reaching toxic thresholds.
Do you have questions about new Alzheimer’s research? Share this article and join the conversation in the comments below.
